Prophylaxis with the Novel Immunomodulator Pidotimod Reduces the Frequency and Severity of Upper Respiratory Tract Infections in Children with Down's Syndrome
Ignazio La Mantia(University of Catania), Ferdinando Nicoletti(University of Catania), M. Di Mauro(University of Catania), Teresa Mattina, Maling Xiang, Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Calogero Grillo, Paola Zaccone(University of Catania)
Cited by 20
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508